These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 38716256)

  • 21. Clinical presentation and recurrence of pituitary neuroendocrine tumors: results from a single referral center in Colombia.
    Jimenez-Canizales CE; Rojas W; Alonso D; Romero I; Tabares S; Veronesi Zuluaga LA; Modica R; Colao A
    J Endocrinol Invest; 2023 Nov; 46(11):2275-2286. PubMed ID: 37002436
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A review of multiomics platforms in pituitary adenoma pathogenesis.
    Mouchtouris N; Smit RD; Piper K; Prashant G; Evans JJ; Karsy M
    Front Biosci (Landmark Ed); 2022 Mar; 27(3):77. PubMed ID: 35345309
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The molecular biology of thyrotroph pituitary neuroendocrine tumors.
    Horiguchi K
    Endocr J; 2023 Feb; 70(2):135-139. PubMed ID: 36653153
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SDF-1α/MicroRNA-134 Axis Regulates Nonfunctioning Pituitary Neuroendocrine Tumor Growth
    Wang X; Fang Y; Zhou Y; Guo X; Xu K; Li C; Zhang J; Hong Y
    Front Endocrinol (Lausanne); 2020; 11():566761. PubMed ID: 33362712
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Progress in the Pathogenesis, Diagnosis, and Treatment of TSH-Secreting Pituitary Neuroendocrine Tumor.
    Luo P; Zhang L; Yang L; An Z; Tan H
    Front Endocrinol (Lausanne); 2020; 11():580264. PubMed ID: 33329389
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Frequency and Role of CDKN2A Deletion in High-Risk Pituitary Neuroendocrine Tumors.
    Kara M; Tokat F; Pamir MN; Danyeli AE
    Endocr Pathol; 2020 Jun; 31(2):166-173. PubMed ID: 32157655
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aggressive pituitary tumors (PitNETs).
    Nishioka H
    Endocr J; 2023 Mar; 70(3):241-248. PubMed ID: 36858483
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Angpt2/Tie2 autostimulatory loop controls tumorigenesis.
    Karabid NM; Wiedemann T; Gulde S; Mohr H; Segaran RC; Geppert J; Rohm M; Vitale G; Gaudenzi G; Dicitore A; Ankerst DP; Chen Y; Braren R; Kaissis G; Schilling F; Schillmaier M; Eisenhofer G; Herzig S; Roncaroli F; Honegger JB; Pellegata NS
    EMBO Mol Med; 2022 May; 14(5):e14364. PubMed ID: 35266635
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multiple tumorous lesions of the pituitary gland.
    Schöning JV; Flitsch J; Lüdecke DK; Fahlbusch R; Buchfelder M; Buslei R; Knappe UJ; Bergmann M; Schulz-Schaeffer WJ; Herms J; Glatzel M; Saeger W
    Hormones (Athens); 2022 Dec; 21(4):653-663. PubMed ID: 35947342
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of cholesterol metabolism-related subtypes in nonfunctioning pituitary neuroendocrine tumors and analysis of immune infiltration.
    Feng T; Hou P; Mu S; Fang Y; Li X; Li Z; Wang D; Chen L; Lu L; Lin K; Wang S
    Lipids Health Dis; 2023 Aug; 22(1):127. PubMed ID: 37563740
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pituitary Tumors: Genetic and Molecular Factors Underlying Pathogenesis and Clinical Behavior.
    Spada A; Mantovani G; Lania AG; Treppiedi D; Mangili F; Catalano R; Carosi G; Sala E; Peverelli E
    Neuroendocrinology; 2022; 112(1):15-33. PubMed ID: 33524974
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epigenomic and somatic mutations of pituitary tumors with clinical and pathological correlations in 111 patients.
    Guaraldi F; Morandi L; Zoli M; Mazzatenta D; Righi A; Evangelisti S; Ambrosi F; Tonon C; Giannini C; Lloyd RV; Asioli S
    Clin Endocrinol (Oxf); 2022 Dec; 97(6):763-772. PubMed ID: 36161330
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genome wide analysis of circulating miRNAs in growth hormone secreting pituitary neuroendocrine tumor patients' plasma.
    Niedra H; Peculis R; Litvina HD; Megnis K; Mandrika I; Balcere I; Romanovs M; Steina L; Stukens J; Breiksa A; Nazarovs J; Sokolovska J; Liutkeviciene R; Vilkevicute A; Konrade I; Rovite V
    Front Oncol; 2022; 12():894317. PubMed ID: 36158656
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantitative Acetylomics Revealed Acetylation-Mediated Molecular Pathway Network Changes in Human Nonfunctional Pituitary Neuroendocrine Tumors.
    Wen S; Li J; Yang J; Li B; Li N; Zhan X
    Front Endocrinol (Lausanne); 2021; 12():753606. PubMed ID: 34712204
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical and Proteomic-Based Molecular Characterizations of Invasive and Noninvasive Somatotroph PitNETs.
    Chen M; Duan L; Sun W; Guo Z; Miao H; Yu N; Yang S; Wang L; Gong F; Yao Y; Zhu H
    Neuroendocrinology; 2023; 113(9):971-986. PubMed ID: 37253344
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Two Pituitary Neuroendocrine Tumors (PitNETs) with Very High Proliferation and TP53 Mutation - High-Grade PitNET or PitNEC?
    Saeger W; Mawrin C; Meinhardt M; Wefers AK; Jacobsen F
    Endocr Pathol; 2022 Jun; 33(2):257-262. PubMed ID: 34669159
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [WHO Histological Classification of Pituitary Tumors].
    Nishioka H
    No Shinkei Geka; 2023 Jul; 51(4):642-653. PubMed ID: 37491061
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The tumour microenvironment of pituitary neuroendocrine tumours.
    Marques P; Grossman AB; Korbonits M
    Front Neuroendocrinol; 2020 Jul; 58():100852. PubMed ID: 32553750
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Establishment of Human Pituitary Neuroendocrine Tumor Derived Organoid and Its Pilot Application for Drug Screening.
    Cui R; Duan H; Hu W; Li C; Zhong S; Liang L; Chen S; Hu H; He Z; Wang Z; Guo X; Chen Z; Xu C; Zhu Y; Chen Y; Sai K; Yang Q; Guo C; Mou Y; Jiang X
    J Clin Endocrinol Metab; 2024 Apr; ():. PubMed ID: 38656317
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical, Biological, Radiological Pathological and Immediate Post-Operative Remission of Sparsely and Densely Granulated Corticotroph Pituitary Tumors: A Retrospective Study of a Cohort of 277 Patients With Cushing's Disease.
    Rak B; Maksymowicz M; Pękul M; Zieliński G
    Front Endocrinol (Lausanne); 2021; 12():672178. PubMed ID: 34135861
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.